腎除神経市場：製品タイプ別（Symplicity、Enlightn、Vessix、Paradise、Iberis、その他）、技術別（無線周波数、超音波、マイクロ注入）、エンドユーザー別（病院、専門クリニック、その他）。世界の機会分析および産業予測、2020-2030年

Renal Denervation Market By Product Type (Symplicity, Enlightn, Vessix, Paradise, Iberis, Others), By Technology (Radiofrequency, Ultrasound, Micro-Infusion), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

腎デナベーションの世界市場規模は、2020年に156,327.4千ドル、2030年には4,555,983.0千ドルに達すると予測されており、2021年から2030年までのCAGRは40.7%を記録しています。腎デナベーションは、患者の高血圧治... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,398 シングルユーザーライセンスライセンス・価格情報注文方法はこちら	195	英語

サマリー

腎デナベーションの世界市場規模は、2020年に156,327.4千ドル、2030年には4,555,983.0千ドルに達すると予測されており、2021年から2030年までのCAGRは40.7%を記録しています。腎デナベーションは、患者の高血圧治療に用いられるカテーテルを用いた最小侵襲性の治療法です。腎除神経は、通常、他の治療法では患者の症状を緩和できない場合に使用されます。この手術では、腎動脈壁神経を超音波または高周波パルスでアブレーションする。したがって、超音波腎除神経は、高血圧患者の血圧を下げるのに役立ちます。
腎除神経市場は、過度のアルコール摂取、運動不足、喫煙、ファーストフードの消費はすべて高血圧のリスク上昇に寄与するため、成長してきました。また、高血圧は、心臓発作や脳卒中、肺動脈性肺高血圧症など、さまざまな疾患の原因となり、高血圧の原因ともなります。そのため、予測期間中は、高血圧やその他の疾患を治療するための腎除神経システムの成長機会が創出されると予想されます。
さらに、高血圧やその他の疾患を治療するための腎除神経装置は、市場の主要な主要プレーヤーによって製造されており、その数は多数あります。例えば、2021年11月に医療機器および技術のメーカーであるMedtronic Plcは、高血圧および糖尿病、慢性腎臓病、孤立性収縮期高血圧などの他の疾患を制御するためのSymplicity腎除神経システムの安全性、耐久性を評価するSpyral Affirm試験を発表しています。
市場は、製品、技術、地域によって区分されます。製品別では、symplicity、enligHTN、vessix、paradise、iberisに区分されます。技術別に見ると、市場は高周波、超音波、マイクロインフュージョンに分けられます。エンドユーザー別に見ると、市場は病院、専門クリニック、その他に分けられます。地域別では、北米（米国、カナダ、メキシコ）、欧州（英国、フランス、ドイツ、イタリア、その他の欧州）、アジア太平洋（中国、日本、インド、オーストラリア、その他のアジア太平洋）、LAMEA（中南米、中東、アフリカ）で市場分析が行われています。

競合分析
世界の腎除神経で活動する主要なプレーヤーは、Ablative Solutions, Inc.、Abbott Laboratories、Johnson & Johnson、Cardiosonic Ltd、Boston Scientific Corporation、Medtronic plc、Mercator MedSystems, Inc、ReCor Medical, Inc、 Renal Dynamics Limited、Terumo Corporationである。

ステークホルダーにとっての主なメリット
本レポートは、現在および新興の腎除神経市場の動向とダイナミクスについて広範な分析を提供します。
2021年から2030年までの主要な市場セグメントの市場推定を構築することで、腎除神経市場の詳細な分析を実施します。
腎除神経市場の広範な分析は、主要製品のポジショニングと市場フレームワーク内の上位競合企業のモニタリングを行うことによって実施されます。
全地域の包括的な分析は、優勢な機会を決定するために提供されます。
2021年から2030年までの世界の腎除神経市場の予測分析が含まれています。
腎除神経市場内の主要なプレーヤーは本レポートでプロファイリングされ、その戦略は徹底的に分析され、腎除神経業界の競争展望の理解に役立っています。

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: RENAL DENERVATION MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Symplicity
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Enlightn
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Vessix
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Paradise
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Iberis
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Others
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: RENAL DENERVATION MARKET, BY TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 Radiofrequency
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Ultrasound
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Micro-Infusion
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: RENAL DENERVATION MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Specialty Clinics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: RENAL DENERVATION MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 Asia-Pacific
7.2.1 Key trends and opportunities
7.2.2 Asia-Pacific Market size and forecast, by Product Type
7.2.3 Asia-Pacific Market size and forecast, by Technology
7.2.4 Asia-Pacific Market size and forecast, by End User
7.2.5 Asia-Pacific Market size and forecast, by country
7.2.5.1 China
7.2.5.1.1 Market size and forecast, by Product Type
7.2.5.1.2 Market size and forecast, by Technology
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 India
7.2.5.2.1 Market size and forecast, by Product Type
7.2.5.2.2 Market size and forecast, by Technology
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Japan
7.2.5.3.1 Market size and forecast, by Product Type
7.2.5.3.2 Market size and forecast, by Technology
7.2.5.3.3 Market size and forecast, by End User
7.2.5.4 Australia
7.2.5.4.1 Market size and forecast, by Product Type
7.2.5.4.2 Market size and forecast, by Technology
7.2.5.4.3 Market size and forecast, by End User
7.2.5.5 Rest of Asia-Pacific
7.2.5.5.1 Market size and forecast, by Product Type
7.2.5.5.2 Market size and forecast, by Technology
7.2.5.5.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Technology
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product Type
7.3.5.1.2 Market size and forecast, by Technology
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product Type
7.3.5.2.2 Market size and forecast, by Technology
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Product Type
7.3.5.3.2 Market size and forecast, by Technology
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product Type
7.3.5.4.2 Market size and forecast, by Technology
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Rest of Europe
7.3.5.5.1 Market size and forecast, by Product Type
7.3.5.5.2 Market size and forecast, by Technology
7.3.5.5.3 Market size and forecast, by End User
7.4 LAMEA
7.4.1 Key trends and opportunities
7.4.2 LAMEA Market size and forecast, by Product Type
7.4.3 LAMEA Market size and forecast, by Technology
7.4.4 LAMEA Market size and forecast, by End User
7.4.5 LAMEA Market size and forecast, by country
7.4.5.1 Latin America
7.4.5.1.1 Market size and forecast, by Product Type
7.4.5.1.2 Market size and forecast, by Technology
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Middle East
7.4.5.2.1 Market size and forecast, by Product Type
7.4.5.2.2 Market size and forecast, by Technology
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Africa
7.4.5.3.1 Market size and forecast, by Product Type
7.4.5.3.2 Market size and forecast, by Technology
7.4.5.3.3 Market size and forecast, by End User
7.5 North America
7.5.1 Key trends and opportunities
7.5.2 North America Market size and forecast, by Product Type
7.5.3 North America Market size and forecast, by Technology
7.5.4 North America Market size and forecast, by End User
7.5.5 North America Market size and forecast, by country
7.5.5.1 U.S.
7.5.5.1.1 Market size and forecast, by Product Type
7.5.5.1.2 Market size and forecast, by Technology
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Canada
7.5.5.2.1 Market size and forecast, by Product Type
7.5.5.2.2 Market size and forecast, by Technology
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 Mexico
7.5.5.3.1 Market size and forecast, by Product Type
7.5.5.3.2 Market size and forecast, by Technology
7.5.5.3.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Ablative Solutions, Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Abbott Laboratories
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Johnson & Johnson
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Cardiosonic Ltd
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Boston Scientific Corporation
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Medtronic plc
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Mercator MedSystems, Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 ReCor Medical, Inc
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Renal Dynamics Limited
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 terumo corporation
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL RENAL DENERVATION MARKET, BY PRODUCT TYPE, 2020-2030,($THOUSAND)
TABLE 2. RENAL DENERVATION MARKET REVENUE, FOR SYMPLICITY, BY REGION , 2020-2030,($THOUSAND)
TABLE 3. RENAL DENERVATION MARKET SYMPLICITY BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 4. RENAL DENERVATION MARKET REVENUE, FOR ENLIGHTN, BY REGION , 2020-2030,($THOUSAND)
TABLE 5. RENAL DENERVATION MARKET ENLIGHTN BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 6. RENAL DENERVATION MARKET REVENUE, FOR VESSIX, BY REGION , 2020-2030,($THOUSAND)
TABLE 7. RENAL DENERVATION MARKET VESSIX BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 8. RENAL DENERVATION MARKET REVENUE, FOR PARADISE, BY REGION , 2020-2030,($THOUSAND)
TABLE 9. RENAL DENERVATION MARKET PARADISE BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 10. RENAL DENERVATION MARKET REVENUE, FOR IBERIS, BY REGION , 2020-2030,($THOUSAND)
TABLE 11. RENAL DENERVATION MARKET IBERIS BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 12. RENAL DENERVATION MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($THOUSAND)
TABLE 13. RENAL DENERVATION MARKET OTHERS BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 14. GLOBAL RENAL DENERVATION MARKET, BY TECHNOLOGY, 2020-2030,($THOUSAND)
TABLE 15. RENAL DENERVATION MARKET REVENUE, FOR RADIOFREQUENCY, BY REGION , 2020-2030,($THOUSAND)
TABLE 16. RENAL DENERVATION MARKET RADIOFREQUENCY BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 17. RENAL DENERVATION MARKET REVENUE, FOR ULTRASOUND, BY REGION , 2020-2030,($THOUSAND)
TABLE 18. RENAL DENERVATION MARKET ULTRASOUND BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 19. RENAL DENERVATION MARKET REVENUE, FOR MICRO-INFUSION, BY REGION , 2020-2030,($THOUSAND)
TABLE 20. RENAL DENERVATION MARKET MICRO-INFUSION BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 21. GLOBAL RENAL DENERVATION MARKET, BY END USER, 2020-2030,($THOUSAND)
TABLE 22. RENAL DENERVATION MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($THOUSAND)
TABLE 23. RENAL DENERVATION MARKET HOSPITALS BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 24. RENAL DENERVATION MARKET REVENUE, FOR SPECIALTY CLINICS, BY REGION , 2020-2030,($THOUSAND)
TABLE 25. RENAL DENERVATION MARKET SPECIALTY CLINICS BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 26. RENAL DENERVATION MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($THOUSAND)
TABLE 27. RENAL DENERVATION MARKET OTHERS BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 28. RENAL DENERVATION MARKET, BY REGION, 2020-2030,($THOUSAND)
TABLE 29. ASIA-PACIFIC RENAL DENERVATION MARKET, BY PRODUCT TYPE, 2020-2030,($THOUSAND)
TABLE 30. ASIA-PACIFIC RENAL DENERVATION MARKET, BY TECHNOLOGY, 2020-2030,($THOUSAND)
TABLE 31. ASIA-PACIFIC RENAL DENERVATION MARKET, BY END USER, 2020-2030,($THOUSAND)
TABLE 32. ASIA-PACIFIC RENAL DENERVATION MARKET, BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 33. CHINA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 34. CHINA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 35. CHINA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 36. INDIA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 37. INDIA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 38. INDIA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 39. JAPAN RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 40. JAPAN RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 41. JAPAN RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 42. AUSTRALIA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 43. AUSTRALIA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 44. AUSTRALIA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 45. REST OF ASIA-PACIFIC RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 46. REST OF ASIA-PACIFIC RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 47. REST OF ASIA-PACIFIC RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 48. EUROPE RENAL DENERVATION MARKET, BY PRODUCT TYPE, 2020-2030,($THOUSAND)
TABLE 49. EUROPE RENAL DENERVATION MARKET, BY TECHNOLOGY, 2020-2030,($THOUSAND)
TABLE 50. EUROPE RENAL DENERVATION MARKET, BY END USER, 2020-2030,($THOUSAND)
TABLE 51. EUROPE RENAL DENERVATION MARKET, BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 52. GERMANY RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 53. GERMANY RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 54. GERMANY RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 55. FRANCE RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 56. FRANCE RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 57. FRANCE RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 58. U.K. RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 59. U.K. RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 60. U.K. RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 61. ITALY RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 62. ITALY RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 63. ITALY RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 64. REST OF EUROPE RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 65. REST OF EUROPE RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 66. REST OF EUROPE RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 67. LAMEA RENAL DENERVATION MARKET, BY PRODUCT TYPE, 2020-2030,($THOUSAND)
TABLE 68. LAMEA RENAL DENERVATION MARKET, BY TECHNOLOGY, 2020-2030,($THOUSAND)
TABLE 69. LAMEA RENAL DENERVATION MARKET, BY END USER, 2020-2030,($THOUSAND)
TABLE 70. LAMEA RENAL DENERVATION MARKET, BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 71. LATIN AMERICA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 72. LATIN AMERICA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 73. LATIN AMERICA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 74. MIDDLE EAST RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 75. MIDDLE EAST RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 76. MIDDLE EAST RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 77. AFRICA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 78. AFRICA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 79. AFRICA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 80. NORTH AMERICA RENAL DENERVATION MARKET, BY PRODUCT TYPE, 2020-2030,($THOUSAND)
TABLE 81. NORTH AMERICA RENAL DENERVATION MARKET, BY TECHNOLOGY, 2020-2030,($THOUSAND)
TABLE 82. NORTH AMERICA RENAL DENERVATION MARKET, BY END USER, 2020-2030,($THOUSAND)
TABLE 83. NORTH AMERICA RENAL DENERVATION MARKET, BY COUNTRY, 2020-2030,($THOUSAND)
TABLE 84. U.S. RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 85. U.S. RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 86. U.S. RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 87. CANADA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 88. CANADA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 89. CANADA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 90. MEXICO RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
TABLE 91. MEXICO RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
TABLE 92. MEXICO RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
TABLE 93.ABLATIVE SOLUTIONS, INC: COMPANY SNAPSHOT
TABLE 94.ABLATIVE SOLUTIONS, INC: OPERATING SEGMENTS
TABLE 95.ABLATIVE SOLUTIONS, INC: PRODUCT PORTFOLIO
TABLE 96.ABLATIVE SOLUTIONS, INC: NET SALES,
TABLE 97.ABLATIVE SOLUTIONS, INC: KEY STRATERGIES
TABLE 98.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 99.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 100.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 101.ABBOTT LABORATORIES: NET SALES,
TABLE 102.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 103.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 104.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 105.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 106.JOHNSON & JOHNSON: NET SALES,
TABLE 107.JOHNSON & JOHNSON: KEY STRATERGIES
TABLE 108.CARDIOSONIC LTD: COMPANY SNAPSHOT
TABLE 109.CARDIOSONIC LTD: OPERATING SEGMENTS
TABLE 110.CARDIOSONIC LTD: PRODUCT PORTFOLIO
TABLE 111.CARDIOSONIC LTD: NET SALES,
TABLE 112.CARDIOSONIC LTD: KEY STRATERGIES
TABLE 113.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 114.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 115.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 116.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 117.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 118.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 119.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 120.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 121.MEDTRONIC PLC: NET SALES,
TABLE 122.MEDTRONIC PLC: KEY STRATERGIES
TABLE 123.MERCATOR MEDSYSTEMS, INC: COMPANY SNAPSHOT
TABLE 124.MERCATOR MEDSYSTEMS, INC: OPERATING SEGMENTS
TABLE 125.MERCATOR MEDSYSTEMS, INC: PRODUCT PORTFOLIO
TABLE 126.MERCATOR MEDSYSTEMS, INC: NET SALES,
TABLE 127.MERCATOR MEDSYSTEMS, INC: KEY STRATERGIES
TABLE 128.RECOR MEDICAL, INC: COMPANY SNAPSHOT
TABLE 129.RECOR MEDICAL, INC: OPERATING SEGMENTS
TABLE 130.RECOR MEDICAL, INC: PRODUCT PORTFOLIO
TABLE 131.RECOR MEDICAL, INC: NET SALES,
TABLE 132.RECOR MEDICAL, INC: KEY STRATERGIES
TABLE 133.RENAL DYNAMICS LIMITED: COMPANY SNAPSHOT
TABLE 134.RENAL DYNAMICS LIMITED: OPERATING SEGMENTS
TABLE 135.RENAL DYNAMICS LIMITED: PRODUCT PORTFOLIO
TABLE 136.RENAL DYNAMICS LIMITED: NET SALES,
TABLE 137.RENAL DYNAMICS LIMITED: KEY STRATERGIES
TABLE 138.TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 139.TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 140.TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 141.TERUMO CORPORATION: NET SALES,
TABLE 142.TERUMO CORPORATION: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.RENAL DENERVATION MARKET SEGMENTATION
FIGURE 2.RENAL DENERVATION MARKET,2020-2030
FIGURE 3.RENAL DENERVATION MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.RENAL DENERVATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.RENAL DENERVATION MARKET,BY PRODUCT TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF SYMPLICITY RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ENLIGHTN RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF VESSIX RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PARADISE RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF IBERIS RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 18.RENAL DENERVATION MARKET,BY TECHNOLOGY,2020(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF RADIOFREQUENCY RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF ULTRASOUND RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF MICRO-INFUSION RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 22.RENAL DENERVATION MARKET,BY END USER,2020(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HOSPITALS RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CLINICS RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS RENAL DENERVATION MARKET,2020-2030(%)
FIGURE 26.RENAL DENERVATION MARKET BY REGION,2020
FIGURE 27.CHINA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 28.INDIA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 29.JAPAN RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 30.AUSTRALIA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 31.REST OF ASIA-PACIFIC RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 32.GERMANY RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 33.FRANCE RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 34.U.K. RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 35.ITALY RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 36.REST OF EUROPE RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 37.LATIN AMERICA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 38.MIDDLE EAST RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 39.AFRICA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 40.U.S. RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 41.CANADA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 42.MEXICO RENAL DENERVATION MARKET,2020-2030($THOUSAND)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 46.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47.COMPETITIVE DASHBOARD
FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 49.ABLATIVE SOLUTIONS, INC.: NET SALES ,($THOUSAND)
FIGURE 50.ABBOTT LABORATORIES.: NET SALES ,($THOUSAND)
FIGURE 51.JOHNSON & JOHNSON.: NET SALES ,($THOUSAND)
FIGURE 52.CARDIOSONIC LTD.: NET SALES ,($THOUSAND)
FIGURE 53.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($THOUSAND)
FIGURE 54.MEDTRONIC PLC.: NET SALES ,($THOUSAND)
FIGURE 55.MERCATOR MEDSYSTEMS, INC.: NET SALES ,($THOUSAND)
FIGURE 56.RECOR MEDICAL, INC.: NET SALES ,($THOUSAND)
FIGURE 57.RENAL DYNAMICS LIMITED.: NET SALES ,($THOUSAND)
FIGURE 58.TERUMO CORPORATION.: NET SALES ,($THOUSAND)

ページTOPに戻る

Table of Contents

Summary

The global renal denervation market size was valued at $156,327.4 thousand in 2020, and is projected to reach $4,555,983.0thousandby 2030, registering a CAGR of 40.7% from 2021 to 2030.Renal denervation is a catheter-based minimally invasive therapy used to treat hypertension in patients. Renal denervation is usually used when other treatments have failed to relieve the patient's symptoms. The renal artery wall nerves are ablated with ultrasound or radio frequency pulses in this operation. Hence, ultrasound renal denervation helps in reducing blood pressure in patient with hypertension.
The renal denervation market has grown owning to excessive alcohol consumption, lack of physical exercises &activities, smoking, and fast-food consumption all contribute to an increased risk of hypertension. Further, it causes various disorders, such as heart attacks, stroke, pulmonary arterial hypertension, and also cause high blood pressure. As a result, during the forecast period, such factor is expected to create growth opportunity for renal denervation system for treating hypertension and other diseases.
Furthermore, there is large number of renal denervation devices, which are manufactured by major key players in the market to treat hypertension and other diseases. For instance, in November 2021, Medtronic Plc, manufacturer of medical devices and technologies announced Spyral Affirm study evaluating safety, durability of Symplicity renal denervation system to control hypertension and other disorder such as diabetes, chronic kidney disease, and isolated systolic hypertension.
The market is segmented on the basis of product, technology, and geography. On the basis of product, the market is divided into symplicity, enligHTN, vessix, paradise, and iberis. On the basis of technology, the market is divided into radiofrequency, ultrasound, and micro-infusion. On the basis of end user, the market is divided into hospitals, specialty clinics, and others. Region wise, the market analysis is conducted across North America (the U.S., Canada, and Mexico), Europe (the UK, France, Germany, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

COMPETITION ANALYSIS
The key players that operate in the global renal denervation are Ablative Solutions, Inc., Abbott Laboratories, Johnson & Johnson, Cardiosonic Ltd, Boston Scientific Corporation, Medtronic plc, Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, and Terumo Corporation.

KEY BENEFITS FOR STAKEHOLDERS
The report provides an extensive analysis of the current and emerging renal denervation market trends and dynamics.
In-depth renal denervation market analysis is conducted by constructing market estimations for key market segments between 2021 and 2030.
Extensive analysis of the renal denervation market is conducted by following key product positioning and monitoring of top competitors within the market framework.
A comprehensive analysis of all the regions is provided to determine the prevailing opportunities.
The global renal denervation market forecast analysis from 2021 to 2030 is included in the report.
The key players within renal denervation market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the renal denervation industry.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（在宅・地域医療）の最新刊レポート

Allied Market Research社の在宅・地域医療分野での最新刊レポート

本レポートと同じKEY WORD（clinics）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（在宅・地域医療）の最新刊レポート

Allied Market Research社の在宅・地域医療分野での最新刊レポート

本レポートと同じKEY WORD（clinics）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?